China's First Alzheimer's Drug Enters US Trials To Much Fanfare
China's first domestically developed Alzheimer’s drug inches closer to US market as FDA approves trials with Green Valley's GV-971.
China's first domestically developed Alzheimer’s drug inches closer to US market as FDA approves trials with Green Valley's GV-971.